Mostrar registro simples

dc.contributor.authorJaisamrarn, Unnoppt_BR
dc.contributor.authorCastellsague, Xavierpt_BR
dc.contributor.authorGarland, Suzanne M.pt_BR
dc.contributor.authorNaud, Paulo Sergio Vieropt_BR
dc.contributor.authorPalmroth, Johannapt_BR
dc.contributor.authorDel Rosario-Raymundo, Maria Rowenapt_BR
dc.contributor.authorWheeler, Cosette M.pt_BR
dc.contributor.authorSalmerón, Jorgept_BR
dc.contributor.authorChow, Song-Nanpt_BR
dc.contributor.authorApter, Dan L.pt_BR
dc.contributor.authorTeixeira, Júlio Césarpt_BR
dc.contributor.authorSkinner, S. Rachelpt_BR
dc.contributor.authorHedrick, James A.pt_BR
dc.contributor.authorSzarewski, Annept_BR
dc.contributor.authorRomanowski, Barbarapt_BR
dc.contributor.authorAoki, Fred Y.pt_BR
dc.contributor.authorSchwarz, Tino F.pt_BR
dc.contributor.authorPoppe, Willy A. J.pt_BR
dc.contributor.authorBosch, F. Xavierpt_BR
dc.contributor.authorCarvalho, Newton S. dept_BR
dc.contributor.authorGermar, Maria Julieta V.pt_BR
dc.contributor.authorPeters, Klauspt_BR
dc.contributor.authorPaavonen, Jormapt_BR
dc.contributor.authorBozonnat, Marie-Cecilept_BR
dc.contributor.authorDescamps, Dominiquept_BR
dc.contributor.authorStruyf, Frankpt_BR
dc.contributor.authorDubin, Garypt_BR
dc.contributor.authorRosillon, Dominiquept_BR
dc.contributor.authorBaril, Laurencept_BR
dc.contributor.authorHPV PATRICIA Study Grouppt_BR
dc.date.accessioned2015-04-15T01:58:11Zpt_BR
dc.date.issued2013pt_BR
dc.identifier.issn1932-6203pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/115337pt_BR
dc.description.abstractBackground: The control arm of PATRICIA (PApillomaTRIal against Cancer In young Adults, NCT00122681) was used to investigate the risk of progression from cervical HPV infection to cervical intraepithelial neoplasia (CIN) or clearance of infection, and associated determinants. Methods and Findings: Women aged 15-25 years were enrolled. A 6-month persistent HPV infection (6MPI) was defined as detection of the same HPV type at two consecutive evaluations over 6 months and clearance as ≥2 typespecific HPV negative samples taken at two consecutive intervals of approximately 6 months following a positive sample. The primary endpoint was CIN grade 2 or greater (CIN2+) associated with the same HPV type as a 6MPI. Secondary endpoints were CIN1+/CIN3+ associated with the same HPV type as a 6MPI; CIN1+/CIN2+/CIN3+ associated with an infection of any duration; and clearance of infection. The analyses included 4825 women with 16,785 infections (3363 womenwith 6902 6MPIs). Risk of developing a CIN1+/CIN2+/CIN3+ associated with same HPV type as a 6MPI varied with HPV type and was significantly higher for oncogenic versus non-oncogenic types. Hazard ratios for development of CIN2+ were 10.44 (95% CI: 6.96-15.65), 9.65 (5.97-15.60), 5.68 (3.50-9.21), 5.38 (2.87-10.06) and 3.87 (2.38-6.30) for HPV-16, HPV-33, HPV-31, HPV-45 and HPV-18, respectively. HPV-16 or HPV-33 6MPIs had ~25-fold higher risk for progression to CIN3+. Previous or concomitant HPV infection or CIN1+ associated with a different HPV type increased risk. Of the different oncogenic HPV types, HPV-16 and HPV-31 infections were least likely to clear. Conclusions: Cervical infections with oncogenic HPV types increased the risk of CIN2+ and CIN3+. Previous or concomitant infection or CIN1+ also increased the risk. HPV-16 and HPV-33 have by far the highest risk of progression to CIN3+, and HPV-16 and HPV-31 have the lowest chance of clearance.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofPloS one. San Francisco, CA. Vol. 8, no. 11 (Nov. 2013), e79260, 15 p.pt_BR
dc.rightsOpen Accessen
dc.subjectInfecções por papillomaviruspt_BR
dc.titleNatural history of progression of HPV infection to cervical lesion or clearance : analysis of the control arm of the large, randomised PATRICIA studypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb000953996pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples